Notice of Public Hearing: Kentucky Opioid Abatement Advisory Commission to Hear Personal Testimonies Supporting $42 Million Funding for Ibogaine Research

With Dr. Andrew Huberman, Rep. Dan Crenshaw, Dr. Nolan Williams, Survivor winner Mike Gabler, comedian Brent Pella, and many more

Program starts October 28

25 graduates prepare to be among the first licensed Psilocybin Facilitators under Oregon's Measure 109

New partnership will provide Phaneros Institute with unlimited access to Fluence's educational content and psychedelic therapy training resources

Expert clinicians and researchers to provide testimony at public hearing on July 17, 2023

Specializing in personalized experiences, the new program offers immersive retreats blending plant medicine, tailored workshops, and pre- and post-retreat support.

New research reveals psychedelic helpline's impact on mitigating risks, preventing emergency calls, and easing the burden on medical services

Self-compassion, emotional regulation, and feelings of connectedness may contribute to the effectiveness of treatment

CONTACT: Brad Burge, Integration Communicationsbrad@integrationcommunications.com